846 related articles for article (PubMed ID: 27592232)
1. Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.
Polcwiartek C; Vang T; Bruhn CH; Hashemi N; Rosenzweig M; Nielsen J
Psychopharmacology (Berl); 2016 Oct; 233(21-22):3663-3672. PubMed ID: 27592232
[TBL] [Abstract][Full Text] [Related]
2. Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature.
Vuk A; Kuzman MR; Baretic M; Osvatic MM
Psychiatr Danub; 2017 Jun; 29(2):121-135. PubMed ID: 28636569
[TBL] [Abstract][Full Text] [Related]
3. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
5. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
Burke KR; Schumacher CA; Harpe SE
Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088
[TBL] [Abstract][Full Text] [Related]
6. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
Newcomer JW
CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
[TBL] [Abstract][Full Text] [Related]
7. Diabetic ketoacidosis and diabetes associated with antipsychotic exposure among a previously diabetes-naive population with schizophrenia: a nationwide nested case-control study.
Polcwiartek C; Kragholm K; Rohde C; Hashemi N; Vang T; Nielsen J
Diabetologia; 2017 Sep; 60(9):1678-1690. PubMed ID: 28593353
[TBL] [Abstract][Full Text] [Related]
8. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
9. Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases.
Jin H; Meyer JM; Jeste DV
Ann Clin Psychiatry; 2002 Mar; 14(1):59-64. PubMed ID: 12046641
[TBL] [Abstract][Full Text] [Related]
10. Diabetic keto-acidotic (DKA) coma following olanzapine initiation in a previously euglycaemic woman and successful continued therapy with olanzapine.
Howes OD; Rifkin L
J Psychopharmacol; 2004 Sep; 18(3):435-7. PubMed ID: 15358991
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review.
Fazeli Farsani S; Brodovicz K; Soleymanlou N; Marquard J; Wissinger E; Maiese BA
BMJ Open; 2017 Aug; 7(7):e016587. PubMed ID: 28765134
[TBL] [Abstract][Full Text] [Related]
12. Euglycemic clamp study in clozapine-induced diabetic ketoacidosis.
Avram AM; Patel V; Taylor HC; Kirwan JP; Kalhan S
Ann Pharmacother; 2001 Nov; 35(11):1381-7. PubMed ID: 11724088
[TBL] [Abstract][Full Text] [Related]
13. Second-Generation Antipsychotics During the Lactation Period: A Comparative Systematic Review on Infant Safety.
Uguz F
J Clin Psychopharmacol; 2016 Jun; 36(3):244-52. PubMed ID: 27028982
[TBL] [Abstract][Full Text] [Related]
14. Risk evaluation of diabetic ketoacidosis associated with antipsychotics among patients with schizophrenia in the Japanese adverse event report database.
Sugawara N; Yasui-Furukori N; Shimoda K
J Psychosom Res; 2023 Dec; 175():111533. PubMed ID: 37866219
[TBL] [Abstract][Full Text] [Related]
15. Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine.
Ramaswamy K; Kozma CM; Nasrallah H
Drug Saf; 2007; 30(7):589-99. PubMed ID: 17604410
[TBL] [Abstract][Full Text] [Related]
16. Treatment Modality-Dependent Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes: Danish Adult Diabetes Database Study.
Hoshina S; Andersen GS; Jørgensen ME; Ridderstråle M; Vistisen D; Andersen HU
Diabetes Technol Ther; 2018 Mar; 20(3):229-234. PubMed ID: 29437465
[TBL] [Abstract][Full Text] [Related]
17. Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression.
Musso G; Sircana A; Saba F; Cassader M; Gambino R
PLoS Med; 2020 Dec; 17(12):e1003461. PubMed ID: 33373368
[TBL] [Abstract][Full Text] [Related]
18. Integrative traditional Chinese medicine therapy reduces the risk of diabetic ketoacidosis in patients with type 1 diabetes mellitus.
Lien AS; Jiang YD; Mou CH; Sun MF; Gau BS; Yen HR
J Ethnopharmacol; 2016 Sep; 191():324-330. PubMed ID: 27340102
[TBL] [Abstract][Full Text] [Related]
19. Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies.
Bernardo M; Rico-Villademoros F; García-Rizo C; Rojo R; Gómez-Huelgas R
Adv Ther; 2021 May; 38(5):2491-2512. PubMed ID: 33826090
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia and antipsychotic medications.
Haupt DW; Newcomer JW
J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
